Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease
US6982154B2 · kind B2 · utility
1Cited by
27References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 1, 2003 |
| Grant date | Jan 3, 2006 |
| Priority date | — |
| Expiry date | Dec 9, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Sickle-cell diseases are treated with annexin proteins that are modified to increase their half-life in the circulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.